We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$5.76B
AUM Growth
+$255M
Cap. Flow
-$50.1M
Cap. Flow %
-0.87%
Top 10 Hldgs %
38.3%
Holding
755
New
16
Increased
65
Reduced
197
Closed
71

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$61.5M
2
PAYC icon
Paycom
PAYC
+$12.9M
3
ROP icon
Roper Technologies
ROP
+$10M
4
TEL icon
TE Connectivity
TEL
+$8.78M
5
MSFT icon
Microsoft
MSFT
+$5.78M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$15.5M
2
GILD icon
Gilead Sciences
GILD
+$13.5M
3
MA icon
Mastercard
MA
+$12M
4
WAB icon
Wabtec
WAB
+$10.6M
5
INTU icon
Intuit
INTU
+$7.56M

Sector Composition

Rank Sector Weight
1 Technology 28.91%
2 Healthcare 17.76%
3 Financials 10.38%
4 Consumer Discretionary 9.44%
5 Consumer Staples 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBE icon
476
State Street SPDR S&P Bank ETF
KBE
$1.74B
$28K ﹤0.01%
600
LBTYA icon
477
Liberty Global Class A
LBTYA
$3.55B
$28K ﹤0.01%
1,031
CAC icon
478
Camden National
CAC
$990M
$27K ﹤0.01%
600
FBRX icon
479
Forte Biosciences
FBRX
$1.57B
$27K ﹤0.01%
8
PHX
480
DELISTED
PHX Minerals
PHX
$27K ﹤0.01%
1,405
VFH icon
481
Vanguard Financials ETF
VFH
$13.9B
$27K ﹤0.01%
400
AKAM icon
482
Akamai
AKAM
$17.6B
$26K ﹤0.01%
350
CAH icon
483
Cardinal Health
CAH
$54.5B
$26K ﹤0.01%
530
-473
-47% -$26.8K
GWW icon
484
W.W. Grainger
GWW
$61.5B
$26K ﹤0.01%
85
-241
-74% -$72K
IFN
485
Aberdeen India Fund
IFN
$509M
$26K ﹤0.01%
1,069
CATC
486
DELISTED
CAMBRIDGE BANCORP
CATC
$26K ﹤0.01%
300
DATA
487
DELISTED
Tableau Software, Inc.
DATA
$26K ﹤0.01%
265
MTRN icon
488
Materion
MTRN
$5.9B
$25K ﹤0.01%
457
-43
-9% -$2.33K
VNQI icon
489
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
$25K ﹤0.01%
435
RWO icon
490
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.28B
$24K ﹤0.01%
500
VOO icon
491
Vanguard S&P 500 ETF
VOO
$1.03T
$24K ﹤0.01%
98
WDAY icon
492
Workday
WDAY
$43.3B
$24K ﹤0.01%
200
BME icon
493
BlackRock Health Sciences Trust
BME
$577M
$23K ﹤0.01%
600
PSA icon
494
Public Storage
PSA
$60.4B
$23K ﹤0.01%
100
TV icon
495
Televisa
TV
$1.49B
$23K ﹤0.01%
1,200
+600
+100% +$10.6K
FRME icon
496
First Merchants
FRME
$2.72B
$22K ﹤0.01%
480
TRI icon
497
Thomson Reuters
TRI
$44.5B
$22K ﹤0.01%
474
WBK
498
DELISTED
Westpac Banking Corporation
WBK
$22K ﹤0.01%
1,000
LH icon
499
Labcorp
LH
$26.2B
$21K ﹤0.01%
134
TMP icon
500
Tompkins Financial
TMP
$1.44B
$21K ﹤0.01%
250

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Loring Wolcott & Coolidge Fiduciary Advisors held 755 positions worth $5.76B, up 4.6% from $5.5B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2018 filing shows 16 new, 65 increased, 197 reduced and 71 closed positions. Its largest new stake was Qualys: 8,780 shares worth $740K. The largest sale was RTX Corp, an estimated $15.5M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q2 2018 buy was Qualys: 8,780 shares worth $740K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Becton Dickinson in Q2 2018, an estimated $61.5M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q2 2018 reduction was RTX Corp, cutting an estimated $15.5M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Monsanto Co in Q2 2018, selling an estimated $1.23M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 38% of its $5.76B portfolio in Q2 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 16 new positions and closed 71 in Q2 2018.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 4.6% quarter-over-quarter to $5.76B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.